Keywords: OAB, overactive bladder syndrome; PTNS, percutaneous tibial nerve stimulation; RCT, randomised controlled trial; QoL, quality of life; VAS, visual analogue scale; p.o., per os; SAE, serious adverse event; EC, ethics committee; ICS, International Continenc
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study
Keywords: urinary bladder, overactive; urinary incontinence; onabotulinumtoxinA; quality of life; urinary tract infectionsAE, adverse event; CIC, clean intermittent catheterization; MID, minimally important difference; OAB, overactive bladder syndrome; PVR, post-vo
Efficacy and Safety of Flexible Dose Fesoterodine in Men and Women with Overactive Bladder Symptoms Including Nocturnal Urinary Urgency
Keywords: muscarinic antagonists; urinary bladder, overactive; nocturia; lower urinary tract symptoms; treatment outcomeESS, Epworth Sleepiness Scale; HRQL, health related quality of life; OAB, overactive bladder syndrome; OAB-q, overactive bladder questionnaire; U
Overactive bladder syndrome: Current pathophysiological concepts and therapeutic approaches
Keywords: OAB, overactive bladder syndrome; DO, detrusor overactivity; AM, antimuscarinic agent; ER, extended-release; BTX, botulinum toxin A; PTNS, posterior tibial nerve stimulation; SNM, sacral neuromodulationOveractive bladder; Antimuscarinics; Botulinum toxin;
The distribution of the prostaglandin E receptor type 2 (EP2) in the detrusor of the guinea pig
Keywords: PG, prostaglandin; PGE2, prostaglandin E2; EP1, prostaglandin E receptor type 1; EP2, prostaglandin E receptor type 2; COX I, cyclo-oxygenase type 1; DO, detrusor overactivity; OAB, overactive bladder syndrome; ICs, interstitial cells; IM-ICs, intramuscle
Satisfaction and Patient Experience With Sacral Neuromodulation: Results of a Single Center Sample Survey
Keywords: urinary bladder; urination disorders; electric stimulation therapy; patient satisfaction; questionnairesINS, internal nerve stimulator; MRI, magnetic resonance imaging; OAB, overactive bladder syndrome; SNM, sacral nerve modulation
Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT Trial
Keywords: urinary bladder; urinary bladder; overactive; electric stimulation therapy; tibial nerve; urinary incontinence; urgeGRA, global response assessment; OAB, overactive bladder syndrome; OAB-q, OAB questionnaire (short form); OrBIT, Overactive Bladder Innovat
Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study
Keywords: urinary incontinence; overactive bladder; anticholinergic; transdermal; oxybutyninAE, adverse event; BMI, body mass index; MITT, modified intent to treat; N-DEO, N-desethyloxybutynin; OAB, overactive bladder syndrome; OTG, oxybutynin chloride topical gel;
Overactive Bladder in Children. Part 2: Management
Keywords: bladder; urinary bladder; overactive; physiopathology; constipation5-HT, serotonin; AC, cingulate gyrus; ACC, anterior cingulate gyrus; DSD, detrusor-sphincter dyssynergia; EMG, electromyography; OAB, overactive bladder syndrome; PCC, posterior cingulate
Overactive Bladder in Children. Part 1: Pathophysiology
Keywords: bladder; urinary bladder; overactive; physiopathology; brain; neurophysiology5-HT, serotonin; ATP, adenosine triphosphate; NA, norepinephrine; OAB, overactive bladder syndrome
Percutaneous Tibial Nerve Stimulation Effects on Detrusor Overactivity Incontinence are Not Due to a Placebo Effect: A Randomized, Double-Blind, Placebo Controlled Trial
Keywords: electric stimulation therapy; tibial nerve; urinary incontinence; placebosDO, detrusor overactivity; GEE, general estimating equations; I-QoL, incontinence quality of life; LUT, lower urinary tract; OAB, overactive bladder syndrome; PTNS, percutaneous tib